Acid sphingomyelinase inhibition suppresses lipopolysaccharide‐mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium‐induced colitis in mice
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Lipopolysaccharide (LPS) and inflammatory cytokines cause activation of sphingomyelinases (SMases) and subsequent hydrolysis of sphingomyelin (SM) to produce a lipid messenger ceramide. The design of SMase inhibitors may offer new therapies for the treatment of LPS‐ and cytokine‐related inflammatory bowel disease. We synthesized a series of difluoromethylene analogues of SM (SMAs). We report here the effects of the most potent SMase inhibitor, SMA‐7, on the LPS‐mediated release of tumour necrosis factor‐α, interleukin‐1β and interleukin‐6 from THP‐1 macrophages and the pathology of dextran sulphate sodium (DSS)‐induced colitis in mice. SMA‐7 suppressed the LPS‐induced cytokine release and nuclear factor‐κB activation. LPS stimulation caused a four‐fold increase in acid SMase activation, but little increase in neutral SMase activity. The presence of 10 μ m SMA‐7 caused acid SMase to remain at the control levels and reduced the formation of ceramide. HT‐29 cells had significantly decreased cell viability when incubated with media from LPS‐stimulated THP‐1 macrophages. However, incubating the colon cells in media from both SMA‐7 and LPS‐treated macrophages caused little decrease in viability, suggesting that ceramide has a role in the LPS‐stimulated signalling that releases cytotoxic factors against colon cells. Oral administration of SMA‐7 to mice with 2% DSS in the drinking water, for 10 or 21 consecutive days, reduced significantly the cytokine levels in the colon and the severity of colonic injury. These findings suggest a central role for acid SMase/ceramide signalling in the pathology of DSS‐induced colitis in mice, indicating a possible preventive or therapeutic role for SMase inhibitor in inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Cited by
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Płóciennikowska, A., Hromada-Judycka, A., Borzęcka, K., & Kwiatkowska, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1762-5 · Cited by 761
Immune–neural connections: how the immune system’s response to infectious agents influences behavior
McCusker, R. H., & Kelley, K. W. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.073411 · Cited by 429
“THE JOURNAL OF EXPERIMENTAL BIOLOGY 92 inflammatory cytokine expression but is a specific MAPK and maybe NF-B pathway accentuator (Medvedev et al., 1999; Sakata et al., 2007).”
BackgroundKornhuber, J., Tripal, P., Reichel, M., Mühle, C., Rhein, C., Muehlbacher, M., Groemer, T. W., & Gulbins, E. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315101 · Cited by 354
Sphingolipids in inflammation: pathological implications and potential therapeutic targets
Nixon, G. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00281.x · Cited by 285
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Kornhuber, J., Muehlbacher, M., Trapp, S., Pechmann, S., Friedl, A., Reichel, M., Mühle, C., Terfloth, L., Groemer, T. W., Spitzer, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023852 · Cited by 176
“Alzheimer’s disease, major depression, inflammatory bowel disease [42], liver cell death and anaemia occurring in Wilson disease, and pulmonary edema in acute lung injury [82].”
Background
Metadata
- Authors
- Sakata, A., Ochiai, T., Shimeno, H., Hikishima, S., Yokomatsu, T., Shibuya, S., Toda, A., Eyanagi, R., & Soeda, S.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2007-04-23
- Volume
- 122
- Issue
- 1
- Pages
- 54-64
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W2022222076
- Cited by
- 108
- References
- 5
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acid sphingomyelinase inhibition suppresses lipopolysaccharide‐mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium‐induced colitis in mice. https://app.cochat.ai/papers/10.1111/j.1365-2567.2007.02612.x
- The paper
- Sakata, A., Ochiai, T., Shimeno, H., Hikishima, S., Yokomatsu, T., Shibuya, S., Toda, A., Eyanagi, R., & Soeda, S. (2007). Acid sphingomyelinase inhibition suppresses lipopolysaccharide‐mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium‐induced colitis in mice. Immunology. https://doi.org/10.1111/j.1365-2567.2007.02612.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.